190 related articles for article (PubMed ID: 37496296)
1. Evidence supporting the choice of a new cardiovascular risk equation for Australia.
Brown S; Banks E; Woodward M; Raffoul N; Jennings G; Paige E
Med J Aust; 2023 Aug; 219(4):173-186. PubMed ID: 37496296
[TBL] [Abstract][Full Text] [Related]
2. Future directions in cardiovascular disease risk prediction.
Doust JA; Bonner C; Bell KJL
Aust J Gen Pract; 2020 Aug; 49(8):488-494. PubMed ID: 32738856
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.
Pylypchuk R; Wells S; Kerr A; Poppe K; Riddell T; Harwood M; Exeter D; Mehta S; Grey C; Wu BP; Metcalf P; Warren J; Harrison J; Marshall R; Jackson R
Lancet; 2018 May; 391(10133):1897-1907. PubMed ID: 29735391
[TBL] [Abstract][Full Text] [Related]
4. 2023 Australian guideline for assessing and managing cardiovascular disease risk.
Nelson MR; Banks E; Brown A; Chow CK; Peiris DP; Stocks NP; Davies Ao R; Raffoul N; Kalman L; Bradburn E; Jennings G
Med J Aust; 2024 May; 220(9):482-490. PubMed ID: 38623719
[TBL] [Abstract][Full Text] [Related]
5. How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000.
Chen L; Rogers SL; Colagiuri S; Cadilhac DA; Mathew TH; Boyden AN; Peeters A; Magliano DJ; Shaw JE; Zimmet PZ; Tonkin AM;
Med J Aust; 2008 Sep; 189(6):319-22. PubMed ID: 18803535
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Disease Implementation and Policy Priorities for Australia: Recommendations From an Australian Stakeholder Roundtable.
Redfern J; Shang C; Hsu MP; Doyle K; Nutbeam D; Audehm R; Inglis SC; Hamilton-Craig C; Raffoul N; Shaw T; Figtree GA; Jennings G;
Heart Lung Circ; 2023 Oct; 32(10):1141-1147. PubMed ID: 37758637
[TBL] [Abstract][Full Text] [Related]
7. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers.
Wells S; Broad J; Jackson R
N Z Med J; 2006 Apr; 119(1232):U1935. PubMed ID: 16633394
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study.
Pylypchuk R; Wells S; Kerr A; Poppe K; Harwood M; Mehta S; Grey C; Wu BP; Selak V; Drury PL; Chan WC; Orr-Walker B; Murphy R; Mann J; Krebs JD; Zhao J; Jackson R
Lancet; 2021 Jun; 397(10291):2264-2274. PubMed ID: 34089656
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
10. Australian general practitioners initiate statin therapy primarily on the basis of lipid levels; New Zealand general practitioners use absolute risk.
Schilling C; Knight J; Mortimer D; Petrie D; Clarke P; Chalmers J; Kerr A; Jackson R
Health Policy; 2017 Dec; 121(12):1233-1239. PubMed ID: 29042060
[TBL] [Abstract][Full Text] [Related]
11. A unified national cardiovascular disease (CVD) risk generator is required to address equity in the management of CVD risk in clinical practice in New Zealand.
Kerr A; Wells S; Moffitt A; Lund M; Kreichbaum J; Harwood M; Jackson R
N Z Med J; 2019 Aug; 132(1500):89-94. PubMed ID: 31415503
[TBL] [Abstract][Full Text] [Related]
12. Are social isolation, lack of social support or loneliness risk factors for cardiovascular disease in Australia and New Zealand? A systematic review and meta-analysis.
Freak-Poli R; Phyo AZZ; Hu J; Barker SF
Health Promot J Austr; 2022 Oct; 33 Suppl 1(Suppl 1):278-315. PubMed ID: 35263481
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million New Zealanders.
Mehta S; Jackson R; Pylypchuk R; Poppe K; Wells S; Kerr AJ
Int J Epidemiol; 2018 Oct; 47(5):1571-1584. PubMed ID: 30010781
[TBL] [Abstract][Full Text] [Related]
14. Which elderly patients should be considered for anti-hypertensive treatment? An evidence-based approach.
Jackson R
J Hum Hypertens; 1998 Sep; 12(9):607-13. PubMed ID: 9783489
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Recommendations and Use of Cardiovascular Risk Equations by Health Technology Assessment Agencies and Clinical Guidelines.
Betts MB; Milev S; Hoog M; Jung H; Milenković D; Qian Y; Tai MH; Kutikova L; Villa G; Edwards C
Value Health; 2019 Feb; 22(2):210-219. PubMed ID: 30711066
[TBL] [Abstract][Full Text] [Related]
16. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.
Mehta S; Wells S; Grey C; Riddell T; Kerr A; Marshall R; Ameratunga S; Harrison J; Kenealy T; Bramley D; Chan WC; Thornley S; Sundborn G; Jackson R
Eur J Prev Cardiol; 2014 Feb; 21(2):192-202. PubMed ID: 23033546
[TBL] [Abstract][Full Text] [Related]
17. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
[TBL] [Abstract][Full Text] [Related]
18. How do cardiovascular risk prediction equations developed among 30-74 year olds perform in older age groups? A validation study in 125 000 people aged 75-89 years.
Mehta S; Jackson R; Poppe K; Kerr AJ; Pylypchuk R; Wells S
J Epidemiol Community Health; 2020 Jun; 74(6):527-533. PubMed ID: 32144211
[TBL] [Abstract][Full Text] [Related]
19. The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5).
Wells S; Kerr A; Broad J; Riddell T; Kenealy T; Jackson R
N Z Med J; 2007 Sep; 120(1261):U2712. PubMed ID: 17853933
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
